IRADIMED CORP (IRMD) Fundamental Analysis & Valuation

NASDAQ:IRMD • US46266A1097

Current stock price

99.5 USD
-0.35 (-0.35%)
At close:
99.5 USD
0 (0%)
After Hours:

This IRMD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. IRMD Profitability Analysis

1.1 Basic Checks

  • IRMD had positive earnings in the past year.
  • IRMD had a positive operating cash flow in the past year.
  • Each year in the past 5 years IRMD has been profitable.
  • Each year in the past 5 years IRMD had a positive operating cash flow.
IRMD Yearly Net Income VS EBIT VS OCF VS FCFIRMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M 15M 20M 25M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 20.67%, IRMD belongs to the top of the industry, outperforming 98.94% of the companies in the same industry.
  • With an excellent Return On Equity value of 23.76%, IRMD belongs to the best of the industry, outperforming 96.30% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 21.02%, IRMD belongs to the best of the industry, outperforming 97.88% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for IRMD is significantly above the industry average of 9.28%.
  • The 3 year average ROIC (20.45%) for IRMD is below the current ROIC(21.02%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 20.67%
ROE 23.76%
ROIC 21.02%
ROA(3y)19.63%
ROA(5y)17.03%
ROE(3y)23.33%
ROE(5y)20.07%
ROIC(3y)20.45%
ROIC(5y)17.53%
IRMD Yearly ROA, ROE, ROICIRMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20 25

1.3 Margins

  • With an excellent Profit Margin value of 26.82%, IRMD belongs to the best of the industry, outperforming 96.83% of the companies in the same industry.
  • IRMD's Profit Margin has improved in the last couple of years.
  • IRMD has a better Operating Margin (31.20%) than 98.41% of its industry peers.
  • In the last couple of years the Operating Margin of IRMD has grown nicely.
  • The Gross Margin of IRMD (76.75%) is better than 88.36% of its industry peers.
  • In the last couple of years the Gross Margin of IRMD has remained more or less at the same level.
Industry RankSector Rank
OM 31.2%
PM (TTM) 26.82%
GM 76.75%
OM growth 3Y2.08%
OM growth 5YN/A
PM growth 3Y3.67%
PM growth 5Y44.08%
GM growth 3Y-0.3%
GM growth 5Y0.65%
IRMD Yearly Profit, Operating, Gross MarginsIRMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. IRMD Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IRMD is creating value.
  • Compared to 1 year ago, IRMD has more shares outstanding
  • The number of shares outstanding for IRMD has been increased compared to 5 years ago.
  • There is no outstanding debt for IRMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IRMD Yearly Shares OutstandingIRMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
IRMD Yearly Total Debt VS Total AssetsIRMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • An Altman-Z score of 57.06 indicates that IRMD is not in any danger for bankruptcy at the moment.
  • IRMD's Altman-Z score of 57.06 is amongst the best of the industry. IRMD outperforms 98.94% of its industry peers.
  • IRMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 57.06
ROIC/WACC1.98
WACC10.59%
IRMD Yearly LT Debt VS Equity VS FCFIRMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 7.98 indicates that IRMD has no problem at all paying its short term obligations.
  • The Current ratio of IRMD (7.98) is better than 87.30% of its industry peers.
  • A Quick Ratio of 6.84 indicates that IRMD has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 6.84, IRMD belongs to the best of the industry, outperforming 87.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.98
Quick Ratio 6.84
IRMD Yearly Current Assets VS Current LiabilitesIRMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. IRMD Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 16.36% over the past year.
  • IRMD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 36.18% yearly.
  • Looking at the last year, IRMD shows a quite strong growth in Revenue. The Revenue has grown by 14.43% in the last year.
  • IRMD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.45% yearly.
EPS 1Y (TTM)16.36%
EPS 3Y20.77%
EPS 5Y36.18%
EPS Q2Q%22.73%
Revenue 1Y (TTM)14.43%
Revenue growth 3Y16.29%
Revenue growth 5Y21.45%
Sales Q2Q%17.03%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.02% on average over the next years. This is quite good.
  • IRMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.59% yearly.
EPS Next Y10.5%
EPS Next 2Y11.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.27%
Revenue Next 2Y10.59%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
IRMD Yearly Revenue VS EstimatesIRMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
IRMD Yearly EPS VS EstimatesIRMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. IRMD Valuation Analysis

4.1 Price/Earnings Ratio

  • IRMD is valuated quite expensively with a Price/Earnings ratio of 51.82.
  • Compared to the rest of the industry, the Price/Earnings ratio of IRMD indicates a somewhat cheap valuation: IRMD is cheaper than 67.72% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.23. IRMD is valued rather expensively when compared to this.
  • Based on the Price/Forward Earnings ratio of 46.90, the valuation of IRMD can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of IRMD indicates a somewhat cheap valuation: IRMD is cheaper than 67.72% of the companies listed in the same industry.
  • IRMD is valuated expensively when we compare the Price/Forward Earnings ratio to 22.42, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 51.82
Fwd PE 46.9
IRMD Price Earnings VS Forward Price EarningsIRMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, IRMD is valued a bit cheaper than 66.67% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, IRMD is valued a bit cheaper than the industry average as 70.90% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 76.95
EV/EBITDA 44.68
IRMD Per share dataIRMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IRMD does not grow enough to justify the current Price/Earnings ratio.
  • IRMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)4.94
PEG (5Y)1.43
EPS Next 2Y11.02%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. IRMD Dividend Analysis

5.1 Amount

  • IRMD has a yearly dividend return of 0.71%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.24, IRMD pays a better dividend. On top of this IRMD pays more dividend than 91.01% of the companies listed in the same industry.
  • With a Dividend Yield of 0.71, IRMD pays less dividend than the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 0.71%

5.2 History

  • IRMD has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
IRMD Yearly Dividends per shareIRMD Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • IRMD pays out 66.90% of its income as dividend. This is not a sustainable payout ratio.
DP66.9%
EPS Next 2Y11.02%
EPS Next 3YN/A
IRMD Yearly Income VS Free CF VS DividendIRMD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
IRMD Dividend Payout.IRMD Dividend Payout, showing the Payout Ratio.IRMD Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IRMD Fundamentals: All Metrics, Ratios and Statistics

IRADIMED CORP

NASDAQ:IRMD (3/20/2026, 8:02:09 PM)

After market: 99.5 0 (0%)

99.5

-0.35 (-0.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)05-04
Inst Owners60.49%
Inst Owner Change3.31%
Ins Owners36.78%
Ins Owner Change-0.61%
Market Cap1.27B
Revenue(TTM)83.81M
Net Income(TTM)22.48M
Analysts82.5
Price Target122.4 (23.02%)
Short Float %6.49%
Short Ratio7.07
Dividend
Industry RankSector Rank
Dividend Yield 0.71%
Yearly Dividend1.18
Dividend Growth(5Y)N/A
DP66.9%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-23
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.78%
Min EPS beat(2)1.27%
Max EPS beat(2)10.29%
EPS beat(4)4
Avg EPS beat(4)5.61%
Min EPS beat(4)0.43%
Max EPS beat(4)10.44%
EPS beat(8)7
Avg EPS beat(8)6.02%
EPS beat(12)10
Avg EPS beat(12)6.52%
EPS beat(16)14
Avg EPS beat(16)7.03%
Revenue beat(2)2
Avg Revenue beat(2)2.2%
Min Revenue beat(2)1.41%
Max Revenue beat(2)3%
Revenue beat(4)3
Avg Revenue beat(4)0.84%
Min Revenue beat(4)-1.05%
Max Revenue beat(4)3%
Revenue beat(8)4
Avg Revenue beat(8)0.28%
Revenue beat(12)7
Avg Revenue beat(12)0.4%
Revenue beat(16)7
Avg Revenue beat(16)0.02%
PT rev (1m)21.21%
PT rev (3m)21.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.26%
EPS NY rev (1m)-1.89%
EPS NY rev (3m)-1.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.52%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.02%
Valuation
Industry RankSector Rank
PE 51.82
Fwd PE 46.9
P/S 15.17
P/FCF 76.95
P/OCF 50.97
P/B 13.44
P/tB 13.94
EV/EBITDA 44.68
EPS(TTM)1.92
EY1.93%
EPS(NY)2.12
Fwd EY2.13%
FCF(TTM)1.29
FCFY1.3%
OCF(TTM)1.95
OCFY1.96%
SpS6.56
BVpS7.4
TBVpS7.14
PEG (NY)4.94
PEG (5Y)1.43
Graham Number17.88
Profitability
Industry RankSector Rank
ROA 20.67%
ROE 23.76%
ROCE 26.52%
ROIC 21.02%
ROICexc 43.68%
ROICexgc 47.04%
OM 31.2%
PM (TTM) 26.82%
GM 76.75%
FCFM 19.72%
ROA(3y)19.63%
ROA(5y)17.03%
ROE(3y)23.33%
ROE(5y)20.07%
ROIC(3y)20.45%
ROIC(5y)17.53%
ROICexc(3y)50.3%
ROICexc(5y)54.7%
ROICexgc(3y)54.98%
ROICexgc(5y)60.13%
ROCE(3y)25.8%
ROCE(5y)22.12%
ROICexgc growth 3Y-13.69%
ROICexgc growth 5YN/A
ROICexc growth 3Y-12.49%
ROICexc growth 5YN/A
OM growth 3Y2.08%
OM growth 5YN/A
PM growth 3Y3.67%
PM growth 5Y44.08%
GM growth 3Y-0.3%
GM growth 5Y0.65%
F-Score6
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 722.21%
Cap/Sales 10.05%
Interest Coverage 250
Cash Conversion 91.34%
Profit Quality 73.51%
Current Ratio 7.98
Quick Ratio 6.84
Altman-Z 57.06
F-Score6
WACC10.59%
ROIC/WACC1.98
Cap/Depr(3y)948.96%
Cap/Depr(5y)635.99%
Cap/Sales(3y)11.43%
Cap/Sales(5y)7.92%
Profit Quality(3y)64.21%
Profit Quality(5y)73.8%
High Growth Momentum
Growth
EPS 1Y (TTM)16.36%
EPS 3Y20.77%
EPS 5Y36.18%
EPS Q2Q%22.73%
EPS Next Y10.5%
EPS Next 2Y11.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)14.43%
Revenue growth 3Y16.29%
Revenue growth 5Y21.45%
Sales Q2Q%17.03%
Revenue Next Year11.27%
Revenue Next 2Y10.59%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.04%
EBIT growth 3Y18.71%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.68%
FCF growth 3Y26.52%
FCF growth 5Y26.12%
OCF growth 1Y-2.64%
OCF growth 3Y35.44%
OCF growth 5Y33.79%

IRADIMED CORP / IRMD Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for IRADIMED CORP?

ChartMill assigns a fundamental rating of 8 / 10 to IRMD.


Can you provide the valuation status for IRADIMED CORP?

ChartMill assigns a valuation rating of 4 / 10 to IRADIMED CORP (IRMD). This can be considered as Fairly Valued.


Can you provide the profitability details for IRADIMED CORP?

IRADIMED CORP (IRMD) has a profitability rating of 9 / 10.


What are the PE and PB ratios of IRADIMED CORP (IRMD) stock?

The Price/Earnings (PE) ratio for IRADIMED CORP (IRMD) is 51.82 and the Price/Book (PB) ratio is 13.44.


Can you provide the financial health for IRMD stock?

The financial health rating of IRADIMED CORP (IRMD) is 9 / 10.